Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-09 | Future report Set alerts | |
Q2 2022 | 2022-08-15 | 12.39 | 12.39 |
Q1 2022 | 2022-05-16 | -5.69 | -5.69 |
Q4 2021 | 2022-03-10 | -0.10 | -0.10 |
Q3 2021 | 2021-11-11 | -0.11 | -0.11 |
Q2 2021 | 2021-08-04 | -0.11 | -0.11 |
Q1 2021 | 2021-05-06 | -0.11 | -0.11 |
Q4 2020 | 2021-03-02 | -0.15 | -0.15 |
Q3 2020 | 2020-11-09 | -0.12 | 0.00 |
Q2 2020 | 2020-08-06 | -0.19 | -0.19 |
2016-07-11 | Reiterated Rating | Noble Financial | Buy | $17.50 |
2016-06-08 | Reiterated Rating | Jefferies Group | Buy | |
2016-04-06 | Reiterated Rating | Jefferies Group | Buy | $18.00 |
2016-04-04 | Initiated Coverage | Goldman Sachs | Buy | $10.00 |
2016-02-28 | Reiterated Rating | Noble Financial | Buy | $18.00 to $17.50 |
2016-02-08 | Reiterated Rating | Jefferies | Buy | $18.00 |
2016-02-08 | Reiterated Rating | Jefferies Group | Buy | $18.00 |
2015-12-08 | Boost Price Target | Jefferies Group | Buy | $15.00 to $18.00 |
2015-12-08 | Boost Price Target | Stifel Nicolaus | Buy | $10.00 to $14.00 |
2015-12-08 | Boost Price Target | Guggenheim | Buy | $33.00 |
2015-10-13 | Reiterated Rating | Noble Financial | Buy | $15.00 |
2015-10-04 | Reiterated Rating | Jefferies Group | Buy | |
2015-09-21 | Boost Price Target | Jefferies Group | Buy | $7.00 to $15.00 |
2015-06-08 | Initiated Coverage | Guggenheim | Buy | $30.00 |
2015-05-29 | Reiterated Rating | Noble Financial | Buy | $15.00 |
2014-07-08 | Initiated | FBR Capital | Outperform | $34 |
2014-07-07 | Initiated Coverage | FBR & Co. | Outperform | $34.00 |
2014-06-17 | Initiated Coverage | JMP Securities | Outperform | $7.00 |
2014-04-17 | Reiterated | Noble Financial | Buy | $9 to $13 |
2014-01-28 | Reiterated | Noble Financial | Buy | $7.25 to $9 |
1970-01-01 |
2016-07-11 | Reiterated Rating | Noble Financial | Buy | $17.50 |
2016-06-08 | Reiterated Rating | Jefferies Group | Buy | |
2016-04-06 | Reiterated Rating | Jefferies Group | Buy | $18.00 |
2016-04-04 | Initiated Coverage | Goldman Sachs | Buy | $10.00 |
2016-02-28 | Reiterated Rating | Noble Financial | Buy | $18.00 to $17.50 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In TXMD 54 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 5.83M |
BlackRock Institutional Trust Company, N.A. | 4.31M |
OPPENHEIMER FUNDS INC | 2.17M |
BlackRock Investment Management, LLC | 0.57M |
TEACHERS ADVISORS INC | 0.49M |
TIAA CREF INVESTMENT MANAGEMENT LLC | 0.34M |
Vanguard Group, Inc | 0.26M |
RUSSELL FRANK CO/ | 0.15M |
MORGAN STANLEY | 0.14M |
BlackRock Group LTD | 0.12M |
EverPoint Asset Management, LLC | 0.12M |
ProShare Advisors LLC | 0.12M |
J. Goldman & Co LP | 82976 |
BLACKROCK ADVISORS LLC | 81862 |
CITADEL ADVISORS LLC | 62562 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Finizio Robert G Chairman/CEO | 13.52% (21061059) | TXMD / |
Bernick Brian | 4.21% (6557371) | TXMD / |
Milligan John C.K. IV President/Secretary | 1.12% (1742419) | TXMD / |
Thompson Tommy G Chairman | 0.44% (679500) | BCR / CGIX / CNC / CYTX / DOC / PURE / TXMD / UTHR / |
C.S. Finance LLC owned by Gerald L. Jensen | 0.23% (357606) | TXMD / |
JENSEN GERALD L President | 0.17% (258878) | TXMD / |
CROFF ENTERPRISES INC President | 0.16% (254488) | TXMD / |
SEGAL NICHOLAS | 0.14% (225809) | TXMD / |
Russell Angus C. | 0.03% (48500) | BTX / ITMN / MNK / QCOR / RVNC / TXMD / |
Collins Cooper C. | 0.02% (36000) | PTX / TXMD / |
Krassan Mitchell EVP, Chief Strategy Officer | 0.02% (30000) | TXMD / |
MUSING JULES A. | 0.01% (22400) | IBIO / TXMD / |
MANDEL RICHARD H JR | 0.01% (13100) | TXMD / |
CARROLL J MARTIN | 0.01% (10000) | CTLT / DRTX / MNK / TXMD / VVUS / |
LaPenta Robert V Jr | 0.01% (10000) | RVLT / TXMD / |